FORA Capital’s AnaptysBio ANAB Stock Holding History

FORA Capital’s Portfolio ANAB Stock Details ANAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-2,536	Closed	-$66K	–	371
2021 Q2	$66K	Buy	+2,536	New	+$60.8K	0.01%	670
2021 Q1	–	Sell	-1,067	Closed	-$23K	–	761
2020 Q4	$23K	Buy	+1,067	New	+$25.9K	﹤0.01%	856
2020 Q3	–	Sell	-4,138	Closed	-$92K	–	646
2020 Q2	$92K	Buy	+4,138	New	+$75.6K	0.03%	511

Other funds holding ANAB

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

FORA Capital's ANAB Position: Q3 2021 in Review

FORA Capital sold out of AnaptysBio (ANAB) in Q3 2021, closing a stake of 2,536 shares — an estimated $66K sold.

FORA Capital first reported a position in ANAB in Q2 2020 and held it in 3 quarters. The position peaked at $92K in Q2 2020. 127 funds tracked by Wall St. Rank hold ANAB as of Q3 2021.

FORA Capital reported no remaining AnaptysBio position as of Q3 2021 after selling out during the quarter.
FORA Capital sold 2,536 AnaptysBio shares in Q3 2021, an estimated $66K.
FORA Capital first reported a position in AnaptysBio in Q2 2020 and held it in 3 quarters.
FORA Capital's AnaptysBio position peaked at $92K in Q2 2020.
127 funds tracked by Wall St. Rank held AnaptysBio as of Q3 2021.

Based on FORA Capital's 13F filing for Q3 2021, filed 15 Nov 2021.